A review published in Genomic Psychiatry by Dr. Peng Lei and colleagues presents a sweeping synthesis of tau protein research that fundamentally reframes our understanding of this molecule's dual ...

Written in collaboration with Tel Aviv University.

Researchers have discovered that newborns have high levels of the tau protein, which is elevated in older people with Alzheimer’s disease, but that it causes them no harm. The discovery opens the door ...

A designer version of the tau protein, developed by a team led by UT Southwestern Medical Center researchers, maintains its ...

A number of neurodegenerative diseases of the brain are characterized by inclusions within neurons that are comprised of aggregated fibrils of hyperphosphorylated tau protein. These disorders, which ...

A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting intermediate soluble tau assemblies ...

The irregular buildup of tau protein in the brain can form “tangles,” which researchers link to several brain disorders, including Alzheimer’s disease. This may have implications for detecting and ...

One dose of a new treatment, delivered by nasal spray, clears away build-ups of the toxic tau protein associated with Alzheimer’s disease from inside brain cells, improving memory, according to new ...

The misfolded proteins tau and α-syn cause irregular aggregation and spread in neurodegenerative illnesses, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In AD, tau protein becomes ...

Dr Miguel Ramirez Moreno studies tau through his work as a postdoctoral researcher with Professor Amrit Mudher, through her AS funded project grant. Miguel has put together this helpful explainer on ...

The overview presentation will review some of the Company’s recent achievements as well as the outlook for upcoming data milestones -JERUSALEM, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd.